Ascendis Pharma AS (MEX:ASNDN) FCF Margin %: -3.13% (As of Mar. 2026)


MEX:ASNDN Ascendis Pharma AS MEX:ASNDN
37 GF Score
Price MXN3,851.44
! 1 Warning Sign
View Full Analysis

What is Ascendis Pharma AS FCF Margin %?

Ascendis Pharma AS MEX:ASNDN 37 FCF Margin % is -3.13% as of Mar. 2026. GuruFocus rates MEX:ASNDN with a GF Score™ of 37/100. The stock has 1 warning sign investors should review. Among 960 Biotechnology companies, Ascendis Pharma AS ranks better than 80.42% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ascendis Pharma AS's Free Cash Flow for the three months ended in Mar. 2026 was MXN-161 Mil. Ascendis Pharma AS's Revenue for the three months ended in Mar. 2026 was MXN5,141 Mil. Therefore, Ascendis Pharma AS's FCF Margin % for the quarter that ended in Mar. 2026 was -3.13%.

As of today, Ascendis Pharma AS's current FCF Yield % is 0.46%.

The historical rank and industry rank for Ascendis Pharma AS's FCF Margin % or its related term are showing as below:

MEX:ASNDN' s FCF Margin % Range Over the Past 10 Years
Min: -6275.92   Med: -1328.91   Max: 6.96
Current: 6.96

During the past 13 years, the highest FCF Margin % of Ascendis Pharma AS was 6.96%. The lowest was -6275.92%. And the median was -1328.91%.

MEX:ASNDN's FCF Margin % is ranked better than
80.42% of 960 companies
in the Biotechnology industry
Industry Median: -85.21 vs MEX:ASNDN: 6.96

Ascendis Pharma AS FCF Margin % Related Terms

Ascendis Pharma AS FCF Margin % Historical Data

* Premium members only.

The historical data trend for Ascendis Pharma AS's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Pharma AS FCF Margin % Chart

Ascendis Pharma AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5,681.20 -996.97 -176.14 -84.60 6.31

Ascendis Pharma AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.18 -4.64 1.01 29.66 -3.13

MEX:ASNDN vs SMMT, BBIO, JAZZ: FCF Margin % Comparison

For the Biotechnology subindustry, Ascendis Pharma AS's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascendis Pharma AS FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma AS's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma AS's FCF Margin % falls into.


MEX:ASNDN
37GF Score
Ascendis Pharma AS MEX:ASNDN
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascendis Pharma AS FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Ascendis Pharma AS's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=957.465/15183.233
=6.31 %

Ascendis Pharma AS's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-160.96/5140.904
=-3.13 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -3.13% mean?
Ascendis Pharma AS (MEX:ASNDN) has a FCF Margin % of -3.13% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ascendis Pharma AS and its competitors. According to the industry distribution chart, Ascendis Pharma AS ranks #188 out of 960 companies in the Biotechnology industry, placing it in the top 19.6%.
Is Ascendis Pharma AS's FCF Margin % too high?
Ascendis Pharma AS's current FCF Margin % is -3.13%. Based on the distribution chart, Ascendis Pharma AS ranks #188 out of 960 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Ascendis Pharma AS has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Ascendis Pharma AS's FCF Margin % compare to SMMT and BBIO?
According to the Biotechnology industry distribution chart, Ascendis Pharma AS ranks #188 out of 960 companies for FCF Margin %. This places Ascendis Pharma AS in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Ascendis Pharma AS and its competitors. Ascendis Pharma AS's current FCF Margin % is -3.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascendis Pharma AS stock overvalued right now?
Ascendis Pharma AS (MEX:ASNDN) has a current FCF Margin % of -3.13%. The current FCF Margin % is -3.13%. Ascendis Pharma AS's overall GF Score™ is 37/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Ascendis Pharma AS (MEX:ASNDN), the current FCF Margin % is -3.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ascendis Pharma AS Business Description

Other Exchanges ASND:USA
Address Tuborg Boulevard 12, Hellerup, DNK, 2900
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
37GF Score

Get the complete analysis for MEX:ASNDN

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,851.44
Price